Appropriateness of Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis

Yijie Liu1, Yuxiong Chen1, Zhen'ge Chang2

  • 1Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China.

Insights

The pooled inappropriate percutaneous coronary intervention (PCI) rate is 6.1% worldwide, with higher rates in non-acute cases. This meta-analysis clarifies PCI appropriateness globally.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Health Services Research

Background:

  • Appropriate Use Criteria (AUC) for coronary revascularization aim to optimize percutaneous coronary interventions (PCIs).
  • Previous studies showed varied rates of inappropriate (rarely appropriate) PCIs across different populations.
  • A comprehensive understanding of the pooled inappropriate PCI rate globally was lacking.

Purpose of the Study:

  • To determine the pooled rate of inappropriate percutaneous coronary interventions (PCIs) worldwide.
  • To compare inappropriate PCI rates between acute and non-acute scenarios.
  • To identify factors influencing inappropriate PCI rates.

Main Methods:

  • A systematic literature search was conducted across PubMed, Cochrane, Embase, and Sinomed databases.
  • Studies reporting inappropriate/rarely appropriate PCI rates were included in a random effects model meta-analysis.
  • Statistical heterogeneity was addressed using a random effects model.

Main Results:

  • Thirty-seven studies involving various PCI scenarios were analyzed.
  • The pooled inappropriate PCI rate was 4.3% in acute scenarios and 8.9% in non-acute scenarios.
  • The overall pooled inappropriate PCI rate was 6.1%, with significantly higher rates in non-acute compared to acute settings.

Conclusions:

  • The global rate of inappropriate PCI is substantial, particularly in non-acute situations.
  • Inappropriate PCI rates did not significantly differ based on study location, development level, or chronic total occlusion presence.
  • Findings underscore the need for adherence to AUC to improve PCI appropriateness.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
15
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
94
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16